Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (151-160 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|December 21, 2022
Zanubrutinib succeeds in head-to-head with ibrutinib in R/R CLLDavid Killock
Nature Reviews. Clinical Oncology|February 16, 2022
Frontline nivolumab combinations improve OS in ESCCDavid Killock
Nature Reviews. Clinical Oncology|April 28, 2022
Prospective insights on the use of bTMBDavid Killock
Nature Reviews. Clinical Oncology|March 22, 2024
IL-13Rα2-targeted CAR T cells show promise in patients with recurrent high-grade gliomasDavid Killock
Nature Reviews. Clinical Oncology|September 27, 2025
ALASCCA: an aspirin a day keeps colorectal cancer awayDavid Killock
Nature Reviews. Clinical Oncology|November 10, 2019
Lorlatinib in ROS1-positive NSCLCDavid Killock
Nature Reviews. Clinical Oncology|March 7, 2018
Sarcoma: Local hyperthermia improves survivalDavid Killock
Nature Reviews. Clinical Oncology|December 19, 2018
mCRC: sequencing in REVERCEDavid Killock
Nature Reviews. Rheumatology|December 18, 2013
Inflammation. Synovitis: are fats in the fire?David Killock
Nature Reviews. Clinical Oncology|December 16, 2021
A new standard for mastocytosisDavid Killock
Pageof 31

Showing results (151-160 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|December 21, 2022
Zanubrutinib succeeds in head-to-head with ibrutinib in R/R CLLDavid Killock
Nature Reviews. Clinical Oncology|February 16, 2022
Frontline nivolumab combinations improve OS in ESCCDavid Killock
Nature Reviews. Clinical Oncology|April 28, 2022
Prospective insights on the use of bTMBDavid Killock
Nature Reviews. Clinical Oncology|March 22, 2024
IL-13Rα2-targeted CAR T cells show promise in patients with recurrent high-grade gliomasDavid Killock
Nature Reviews. Clinical Oncology|September 27, 2025
ALASCCA: an aspirin a day keeps colorectal cancer awayDavid Killock
Nature Reviews. Clinical Oncology|November 10, 2019
Lorlatinib in ROS1-positive NSCLCDavid Killock
Nature Reviews. Clinical Oncology|March 7, 2018
Sarcoma: Local hyperthermia improves survivalDavid Killock
Nature Reviews. Clinical Oncology|December 19, 2018
mCRC: sequencing in REVERCEDavid Killock
Nature Reviews. Rheumatology|December 18, 2013
Inflammation. Synovitis: are fats in the fire?David Killock
Nature Reviews. Clinical Oncology|December 16, 2021
A new standard for mastocytosisDavid Killock
Pageof 31